191 related articles for article (PubMed ID: 11872915)
61. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
62. [Pharmacotherapy of stroke].
Bereczki D
Neuropsychopharmacol Hung; 2009 Mar; 11(1):7-13. PubMed ID: 19731813
[TBL] [Abstract][Full Text] [Related]
63. Gastrointestinal bleeding after acute ischemic stroke.
Misra UK; Kalita J; O'Donnell MJ; Kapral M; Silver F
Neurology; 2009 Jul; 73(2):160-1. PubMed ID: 19597141
[No Abstract] [Full Text] [Related]
64. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
[TBL] [Abstract][Full Text] [Related]
65. Shifting Perceptions of Risk and Reward: Use of Anticoagulation in Patients With Acute Brain Ischemia and Atrial Fibrillation: Nine-Year Data From a National Acute Stroke Registry (National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Tsabari R; Orion D; Merzlyak O; Haratz S; Peretz S; Bornstein NM; Ifergane G; Einhorn M; Schwammenthal E; Geva D; Tanne D;
Stroke; 2017 Apr; 48(4):1092-1094. PubMed ID: 28258255
[TBL] [Abstract][Full Text] [Related]
66. Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.
Kim BJ; Kang HG; Lee DH; Kang DW; Kim JS; Kwon SU
Int J Stroke; 2015 Aug; 10(6):E68. PubMed ID: 26202718
[No Abstract] [Full Text] [Related]
67. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
[TBL] [Abstract][Full Text] [Related]
68. Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.
Shono Y; Sugimori H; Matsuo R; Fukushima Y; Wakisaka Y; Kuroda J; Ago T; Kamouchi M; Kitazono T
Int J Stroke; 2018 Oct; 13(7):734-742. PubMed ID: 29543141
[TBL] [Abstract][Full Text] [Related]
69. Anticoagulation in acute ischaemic stroke: deep vein thrombosis prevention and long-term stroke outcomes.
Lensing AW
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S123-7. PubMed ID: 10493241
[TBL] [Abstract][Full Text] [Related]
70. Role of heparin during endovascular therapy for acute ischemic stroke.
Farook N; Haussen D; Sur S; Snelling B; Gersey Z; Yavagal D; Peterson E
Clin Neurol Neurosurg; 2016 Jun; 145():64-7. PubMed ID: 27088222
[TBL] [Abstract][Full Text] [Related]
71. Safety of heparin in acute ischemic stroke.
Lee N
Neurology; 1996 Feb; 46(2):589; author reply 589-91. PubMed ID: 8614550
[No Abstract] [Full Text] [Related]
72. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.
Padma V; Fisher M; Moonis M
Expert Rev Cardiovasc Ther; 2006 May; 4(3):405-15. PubMed ID: 16716101
[TBL] [Abstract][Full Text] [Related]
73. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
Kumar S; de Lusignan S; McGovern A; Correa A; Hriskova M; Gatenby P; Jones S; Goldsmith D; Camm AJ
BMJ; 2018 Feb; 360():k342. PubMed ID: 29444881
[TBL] [Abstract][Full Text] [Related]
74. Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease.
Liu J; Wang D; Li J; Lin J; Xiong Y; Liu B; Wei C; Wu B; Ma Z; Zhang S; Liu M
Curr Neurovasc Res; 2017; 14(2):104-109. PubMed ID: 28294063
[TBL] [Abstract][Full Text] [Related]
75. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
Yi X; Lin J; Wang C; Zhang B; Chi W
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1537-44. PubMed ID: 24656240
[TBL] [Abstract][Full Text] [Related]
76. Symptomatic hemorrhagic transformation and its predictors in acute ischemic stroke with atrial fibrillation.
Lee JH; Park KY; Shin JH; Cha JK; Kim HY; Kwon JH; Oh HG; Lee KB; Kim DE; Ha SW; Cho KH; Sohn SI; Oh MS; Yu KH; Lee BC; Kwon SU
Eur Neurol; 2010; 64(4):193-200. PubMed ID: 20714158
[TBL] [Abstract][Full Text] [Related]
77. [Prevention of recurrent ischemic stroke: recent clinical trial results].
Mohr JP
Neurologia; 2002; 17(7):378-82. PubMed ID: 12236957
[TBL] [Abstract][Full Text] [Related]
78. Impact of atrial fibrillation and inadequate antithrombotic management on mortality in acute neurovascular syndrome.
Saarinen JT; Rusanen H; Sillanpää N; Huhtala H; Numminen H; Elovaara I
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2256-64. PubMed ID: 25156784
[TBL] [Abstract][Full Text] [Related]
79. Aspirin and heparin in acute ischaemic stroke in older patients.
Gubitz GJ; Sandercock PA
Drugs Aging; 1999 Jul; 15(1):29-36. PubMed ID: 10459730
[TBL] [Abstract][Full Text] [Related]
80. An alternative view of heparin anticoagulation in acute focal brain ischemia.
Phillips SJ
Stroke; 1989 Feb; 20(2):295-8. PubMed ID: 2645694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
